Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T00:37:40.243Z Has data issue: false hasContentIssue false
  • English
  • Français

The pharmacotherapeutic management of rapid cycling affective disorder: an update

Published online by Cambridge University Press:  13 June 2014

Fabrizio Schifano
Fabrizio Schifano*
Affiliation:
Visiting Research Worker at the Institute of Psychiatry, Department of Clinical Psychopharmacology, University of London (UK); and Senior Registrar in Psychiatry, Head of the Alcohol and Drug Addicts Advice Unit, Local Health Unit n.12, Conegliano, Treviso (Italy)
*
Servizio P.C.R. Tossicodipendenze e Alcologia, Viale Spellanzon, 55, 31015 Conegliano (TV), Italy
Get access Rights & Permissions [Opens in a new window]

Abstract

In the present work the author presents a literature update regarding the pharmacotherapeutic management of rapid cycling affective disorder. This phenomenon is characterized, according to Dunner and Fieve (1974), by the presence of at least four affective episodes per year. After a consideration of the clinical features of the disorder, which are in many respects similar to those of the ‘classic’ bipolar disorder, the author describes the different therapeutic strategies available to the psychiatrist. Withdrawal of antidepressant therapy and administration of lithium salts are likely to constitute the best initial approach. In case of treatment non-responsiveness, it is possible to consider the use of different drugs; for example, carbamazepine, sodium valproate, clorgyline, thyroid hormone. To date, the therapeutic management of rapid cyclers remains extremely difficult. Further studies, especially addressed to the aetiopathogenetic aspects of the disorder, are required.

Keywords

rapid cycling affective disorderpharmacotherapeutic managementrapid cyclers
Type
Review Articles
Information
Irish Journal of Psychological Medicine , Volume 7 , Issue 1 , March 1990 , pp. 71 - 78
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dunner, D L and Fieve, R R. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229–33.CrossRefGoogle ScholarPubMed
2.Kraepelin, E. Manic-depressive insanity and paranoia. Edinburgh: H S Livingstone Ltd, 1921.CrossRefGoogle Scholar
3.Zis, AP and Goodwin, FK. Major affective disorder as a recurrent illness. Arch Gen Psychiatry 1979; 36: 835–39.CrossRefGoogle ScholarPubMed
4.Alarcon, RD. Rapid cycling affective disorders: a clinical review. Compr Psychiatry 1985; 26: 522–40.CrossRefGoogle ScholarPubMed
5.Kahlbaum, KL. Die katatonie oder das spannungsirresein. Berlin: Hirschwald, 1874.Google Scholar
6.Dunner, DL, Patrick, V and Fieve, RR. Rapid cycling manic-depressive patients. Compr Psychiatry 1977; 18: 561–66.CrossRefGoogle ScholarPubMed
7.Kukopulos, A, Caliari, B and Tundo, A. Rapid cyclers, temperament and antidepressants. Compr Psychiatry 1983; 24: 249–58.CrossRefGoogle ScholarPubMed
8.Dunner, DL. Rapid cycling bipolar manic depressive illness. Psych Clin North Am. 1979; 2: 461–467.CrossRefGoogle Scholar
9.Doerr, P, Von Zerssen, D and Fischler, M. Relationship between mood changes and adrenal cortical activity in a patient with a 48-hour unipolar-depressive cycles. J Affect Disord 1979; 1:93–104.CrossRefGoogle Scholar
10.Gelenberg, AJ, Klerman, GL and Hartmann, EL. Recurrent unipolar depressions with 48-hour cycle. Br J Psychiatry 1978; 133: 123–9.CrossRefGoogle ScholarPubMed
11.Tondo, L, Laddomada, P, Serra, Get al.Rapid cyclers and anti-depressants. Int Pharmacopsychiat 1981; 16: 119–23.CrossRefGoogle Scholar
12.Cowdry, RW, Wehr, TA, Zis, APet al.Thyroid abnormalities associated with rapid cycling bipolar illness. Arch Gen Psychiatry 1983; 40: 414–20.CrossRefGoogle ScholarPubMed
13.Bunney, WE Jr. and Hartmann, EL. Study of a patient with a 48-hour manic depressive cycle. Arch Gen Psychiatry 1965; 12: 611–18.CrossRefGoogle Scholar
14.Jenner, F A, Gjessing, L R and Cox, J R. A manic-depressive psychotic with a persistent forty-eight hour cycle. Br J Psychiatry 1967; 113: 895–910.CrossRefGoogle ScholarPubMed
15.Kripke, DF, Mullaney, DJ, Atkinson, Met al.Circadian rhythm disorders in manic depressive. Biol Psychiatry 1978; 13: 335–351.Google Scholar
16.Rosenthal, NE, Rosenthal, LN, Stallone, Fet al.Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry 1980; 37: 804–10.CrossRefGoogle ScholarPubMed
17.Wehr, TA, Sack, DA, Rosenthal, NEet al.Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179–184.Google ScholarPubMed
18.Kukopulos, A, Reginaldi, D, Laddomada, Pet al.Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiat 1980; 13: 156–67.CrossRefGoogle Scholar
19.Jupfer, DJ, Carpenter, LL and Frank, E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988; 145: 804–8.Google Scholar
20.Wehr, TA and Goodwin, FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Int Pharmacopsychiat 1981; 16: 119–123.Google Scholar
21.Baastrup, CP and Schou, M. Lithium as a prophylactic agent: its effect against recurrent depression and manic-depressive psychosis. Arch Gen Psychiatry 1967; 16: 162–72.CrossRefGoogle ScholarPubMed
22.Christodoulou, GL, Malliaras, DE, Lyukoras, EPet al.Possible prophylactic effect of sleep deprivation. Am J Psychiatry 1978; 135: 375–6.Google ScholarPubMed
23.Cohen, BM and Baldessarini, RJ. Tolerance to therapeutic effects of antidepressants. Am J Psychiatry 1985; 142: 489–90.Google ScholarPubMed
24.Forrest, D. Bipolar illness following right hemispsherectomy. Arch Gen Psychiatry 1982; 39: 817–23.CrossRefGoogle Scholar
25.Post, RM, Uhde, TW, Ballenger, JCet al.Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 1983; 140: 1602–4.Google ScholarPubMed
26.Mindham, RS, Howland, C and Shepherd, M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 1973; 3: 5–17.CrossRefGoogle ScholarPubMed
27.Prien, RF and Kupfer, DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 1986; 143: 18–23.Google ScholarPubMed
28.Squillace, K, Post, RM, Savard, Ret al.Life charting of the longitudinal course of recurrent affective illness. In: Post, R M and Ballenger, JC eds. Neurobiology of mood disorders. Baltimore: Williams & Wilkins, 1984.Google Scholar
29.Melia, P, O'Sullivan, D and Barry, D. Lithium and rapid-cycling affective disorder: a report on six cases. Irish Journal of Psychological Medicine 1988; 5: 79–83.Google Scholar
30.Roy-Byrne, PP, Joffe, RT, Uhde, TWet al.Approaches to evaluation and treatment of rapid cycling affective illness. Br J Psychiatry 1984; 145: 543–550.CrossRefGoogle ScholarPubMed
31.Hanna, SM, Jenner, FA and Pearson, IB. The therapeutic effect of lithium carbonate on a patient with a 48-hour periodic psychosis. Br J Psychiatry 1972; 121: 271–80.CrossRefGoogle Scholar
32.Naylor, GJ, Reid, AH and Dick, AT. A biochemical study of short-cycle manic-depressive psychosis in mental defectives. Br J Psychiatry 1976; 128: 169–80.CrossRefGoogle ScholarPubMed
33.Paschalis, C, Pavlou, A and Papadimitriou, A. A stepped forty-eight hour manic-depressive cycle. Br J Psychiatry 1980; 137: 332–6.CrossRefGoogle Scholar
34.Nolen, WA. Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiat Scand 1983; 67: 218–25.CrossRefGoogle ScholarPubMed
35.Shukla, S, Cook, BL and Miller, MG. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. J Affect Disord 1985; 9: 219–22.CrossRefGoogle ScholarPubMed
36.Post, RM and Uhde, TW. Carbamazepine in bipolar illness. Psychopharmacol Bull. 1985; 21: 10–17.Google ScholarPubMed
37.Stromgren, L and Boiler, S. Carbamazepine treatment and prophylaxis of manic-depressive disorder. Psychiatr Developm 1985; 4: 349–67.Google Scholar
38.Ballenger, JC and Post, RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Comm Psychopharmacol 1978; 2: 159–75.Google ScholarPubMed
39.Okuma, T, Inanaga, K, Otsuki, Set al.Comparison of antimanic efficacy of carbamazepine and chloropromazine: a double blind controlled study. Psychopharmacology 1979; 139: 939–41.Google Scholar
40.Post, RM, Uhde, TW, Ballenger, JCet al.Carbamazepine and its 10,11-epoxide metabolite in plasma and CSF: relationship to antidepressant response. Arch Gen Psychiatry 1983; 40: 673–676.CrossRefGoogle Scholar
41.Post, RM, Ballenger, JC, Uhde, TWet al.Efficacy of carbamazepine in manic-depressive illness; implications for underlying mechanisms. In: Post, RM & Ballenger, JC, eds. Neurobiology of mood disorders. Baltimore: Williams & Wilkins, 1984.Google Scholar
42.Post, RM and Uhde, TW. Carbamazepine as a treatment for refractory depressive illness and rapidly cycling manic-depressive illness. In: Zohar, J and Belmaker, RH eds. New York: Spectrum Press, 1984.Google Scholar
43.Kishimoto, A, Ogura, C, Hazama, Het al, . Long-term prophylactic effects of carbamazepine in affective disorder. Br J Psychiatry 1983; 43: 327–31.CrossRefGoogle Scholar
44.Joyce, PR. Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 1988; 3: 123–9.CrossRefGoogle ScholarPubMed
45.Wilkus, RJ, Didrill, CB and Troupin, AS. Carbamazepine and the electroencephalogram of epileptics: a double-blind study in comparison to Phenytoin. Epilepsia. 1978; 19: 283–291.CrossRefGoogle ScholarPubMed
46.Yerevanian, B and Hodgmann, CH. A haloperidol-carbamazepine interaction in a patient with rapid cycling bipolar disorder. Am J Psychiatry 1985; 142: 785–86.Google Scholar
47.Emrich, HM. Use of GABAmimetics and anticonvulsants in the treatment of affective disorders. In: Bartolini, Get al, eds. LERS, vol 4. New York: Raven Press, 1986.Google Scholar
48.Emrich, H M, Von Zerssen, D, Kissling, Wet al.Therapeutic effect of valproate in mania. Am J Psychiatry 1981; 138: 256.Google ScholarPubMed
49.Herridge, GL and Pope, HG Jr.Treatment of bulimia and rapid cycling bipolar disorder with sodium valproate: a case report. J Clin Psychopharmacol. 1985; 5: 229–30.CrossRefGoogle ScholarPubMed
50.McElroy, SL, Keck, PE Jr, Pope, HG Jret al.Valproate in the treatment of rapid cycling bipolar disorder. J Clin Psychopharmacol 1988; 8: 275–9.CrossRefGoogle ScholarPubMed
51.Cho, JT, Bone, S and Dunner, DL. The effect of lithium treatment on thyroid function in patients with primary affective disorder. Am J Psychiatry 1979; 136: 115–6.Google ScholarPubMed
52.Sack, DA, James, SP, Rosenthal, Net al.Deficient nocturnal surge of TSH secretion during sleep and sleep deprivation in rapid-cycling bipolar illness. Psychiatry Res 1988; 23: 179–91.CrossRefGoogle ScholarPubMed
53.Stancer, HC and Persad, E. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 1982; 39: 311–2.CrossRefGoogle ScholarPubMed
54.Leibow, D. L-thyroxine for rapid-cycling bipolar illness. Am J Psychiatry 1983; 140: 1255.Google ScholarPubMed
55.Extein, I, Pottash, A and Gold, M. Does subclinical hypothyroidism predispose to tricyclic-induced rapid mood cycles? J Clin Psychiatry 1982; 43: 290–1.Google ScholarPubMed
56.Hatotani, N, Kitayama, I and Inoue, K. Psychoendocrine studies of recurrent psychoses. In: Hatotani, N and Nomura, J, eds. The neurobiology of periodic psychoses. New York: Igaku-Shoin Press, 1984.Google Scholar
57.Bauer, MS and Whybrow, PC. The effect of changing thyroid function on cycling affective illness in a human subject. Am J Psychiatry 1986; 143: 633–6.Google Scholar
58.Potter, WZ, Murphy, DL, Wehr, T Aet al.Clorgyline. Arch Gen Psychiatry 1982; 39: 505–10.CrossRefGoogle ScholarPubMed
59.Himmelhoch, J M. Mixed states, manic-depressive illness and the nature of mood. Psych Clin North Am 1979; 2: 449–59.CrossRefGoogle Scholar
60.Ahlfors, UG, Baastrup, PC, Dencker, SJet al.Flupenthixol decanoate in recurrent manic-depressive illness. Acta Psychiat Scand 1981; 64: 226–37.CrossRefGoogle ScholarPubMed
61.Lowe, MR and Batchelor, DH. Depot neuroleptics and manic depressive psychosis. Int Clin Psychopharmacol 1986; 1: 53–62.Google ScholarPubMed
62.Carman, JS and Wyatt, RI. Use of calcitonin in psychotic agitation or mania. Arch Gen Psychiatry 1979; 36: 72–5.CrossRefGoogle ScholarPubMed
63.Brotman, AW, Farhadi, AM and Gelenberg, AJ. Verapamil treatment of acute mania J Clin Psychiatry 1986; 47: 136–8.Google ScholarPubMed
64.Dubovsky, SL, Franks, RD, Lifschitz, MLet al.Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiatry 1982; 135: 502–4.Google Scholar
65.Giannini, AJ, Loiselle, RH, Price, WAet al.Comparison of antimanic efficacy of clonidine and verapamil. J Clin Pharmacology 1985; 25: 307–8.CrossRefGoogle ScholarPubMed
66.Shaw, DM. Drug alternatives to lithium in manic-depressive disorders. Drugs 1988; 36: 249–255.CrossRefGoogle ScholarPubMed
67.Goldstein, JA. Danazol and the rapid cycling patient. J Clin Psychiatry 1986; 47: 153–4.Google ScholarPubMed
68.Oppenheim, G. Drug-induced rapid mood cycling with estrogen: implications for therapy. J Clin Psychiatry 1984; 45: 34–45.Google Scholar
69.Giannini, AJ, Pascarzi, GA, Loiselle, RHet al.Lithium in the treatment of mania. Am J Psychiatry 1986; 143: 1608–1609.Google ScholarPubMed
70.Berman, E and Wolpert, EA. Intractable manic-depressive psychosis with rapid cycling in an 18-year-old woman successfully treated with electroconvulsive therapy. J Nerv Ment Dis 1987; 175: 236–9.CrossRefGoogle Scholar
71.Feighner, P. Clinical efficacy of the newer antidepressants. J Clin Psychopharmacol 1981; 1: 235–65.CrossRefGoogle Scholar
72.Nurnberger, J, Guroff, JJ, Hamovit, Jet al.A family study of rapid cycling bipolar illness. J Affect Disord 1988; 15: 87–91.CrossRefGoogle ScholarPubMed
73.Gold, PW, Extein, I, Ballenger, JCet al.Rapid mood cycling and concomitant cortisol changes produced by cyproheptadine. Am J Psychiatry 1980; 137: 378–9.Google ScholarPubMed
74.Dilsaver, SC, Kronfol, Z and Scalkellares, J. Antidepressant withdrawal syndromes evidence supporting the cholinergic over-drive hypothesis. J Clin Psychopharmacol 1983; 3: 157–64.Google Scholar
75.Gay, C, Poirier, MF and Olie, JP. Aspects cliniques et ethiopathogenetiques des psychoses maniaco-depressive a cycle rapide. Ann Med Psychol 1987; 145: 83–90.Google Scholar
76.Levy, AB, Drake, ME and Shy, KE. EEG evidence of epileptiform paroxysms in rapid cycling bipolar patients. J Clin Psychiatry 1988; 49: 232–4.Google ScholarPubMed
77.Gerner, RH, Post, RM and Bunney, E Jr.A dopaminergic mechanism in mania. Am J Psychiatry 1976; 133: 1177–80.Google ScholarPubMed
78.Ko, GN, Leckman, JF and Heninger, GR. Induction of rapid mood cycling during L-dopa treatment in a bipolar patient. Am J Psychiatry 1981; 138: 1624–5.Google Scholar
79.Lerer, B, Birmacher, B and Ebstein, RP. 48-hour depressive cycling induced by antidepressant. Br J Psychiatry 1980; 137: 183–5.CrossRefGoogle ScholarPubMed
80.Oppenheim, G. Drug-induced rapid cycling: Possible outcomes and management. Am J Psychiatry 1982; 139: 939–41.Google ScholarPubMed
81.Alarcon, RD, Shirriff, JR and Kern, EE. Euthyroid hyperthyroxinemia and rapid cycling affective disorder: case report. J Clin Psychiatry 1985; 46: 61–3.Google ScholarPubMed
82.Kellner, CH, Davenport, Y and Post, RM. Rapidly cycling bipolar disorder and multiple sclerosis. Am J Psychiatry 1984; 141: 112–3.Google ScholarPubMed
83.Tundo, A, Cassano, GB, Psicosi maniaco depressiva con decorso circolare continuo a cicli rapidi. Quad Ital Psichiatria 1989; 5: 363–378.Google Scholar
84.Lewis, J, Winokur, G. Induction of mania by antidepressants. Am J Psychiatry 1989; 146: 126–127 (letter).Google ScholarPubMed
85.Wehr, TA, Goodman, FK. Drs. Wehr and Goodwin reply. Am J Psychiatry 1989; 146: 127–128 (letter).CrossRefGoogle Scholar
86.Tundo, A, Reginaldi, D. Influenza degli antidepressivi sul decorso dei disturbi affettivi. Quad Ital psichiatria 1989; 5: 413–428.Google Scholar
87.Schou, M. Lithium prophylaxis: myths and realities. Am J Psychiatry 1989; 146: 573–576.Google ScholarPubMed
88.Aronson, TA, Shukla, S, Hirschowitz, J. Clonazepam treatment of five lithium refractory patients with bipolar disorder. Am J Psychiatry 1989; 146: 77–80.Google ScholarPubMed